Combination of a statin and a fibrate, this time fixed-dose

Abstract

The addition of fenofibrate to the therapy with a statin in patients with inadequately controlled hypertriglyceridemiareduces the risk of macrovascular events, and impacts positively on the course of microvascular damage in patients with insulin resistance of manifest diabetes mellitus.

Keywords

• Statins
• combination
• fixe-dose combination
• residual cardiovascular risk
• dyslipidaemia